Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis
Kim Hoffman, Canyon Foot, Ximena A. Levander, Ryan Cook, Javier Ponce Terashima, John W. McIlveen, P. Todd Korthuis, Dennis McCarty
Topics & Concepts
MethadoneDosingCoronavirus disease 2019 (COVID-19)Opioid use disorderOpioidMedicineOpiate Substitution Treatment2019-20 coronavirus outbreakAnesthesiaIntensive care medicinePharmacologyBuprenorphineInternal medicineVirologyOutbreakReceptorDiseaseInfectious disease (medical specialty)Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPain Management and Opioid Use